← Back to Search

CRC mHealth for Colorectal Cancer Screening

N/A
Recruiting
Led By Samantha L Leaf, Ph.D.
Research Sponsored by ISA Associates, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
personal history of colorectal cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 6
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new program to see if it helps African American men get screened for colorectal cancer. Participants get text messages and videos to help them overcome barriers to screening.

Who is the study for?
This trial is for African American men who aren't up-to-date with colorectal cancer screenings, own a smartphone capable of texting and web access, and speak English. Men with a personal history of colorectal cancer cannot participate.
What is being tested?
The study tests if an mHealth program on smartphones increases the rate at which African American men get screened for colorectal cancer compared to those who just receive standard CDC educational texts.
What are the potential side effects?
Since this intervention involves information via text messages and does not include medication or medical procedures, there are no direct physical side effects associated with participating in this clinical trial.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have had colorectal cancer in the past.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 6 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Receipt of Colorectal Cancer Screening Test at Month 6
Secondary study objectives
Change from Baseline in Cancer Fatalism at Month 6
Change from Baseline in Colorectal Cancer Knowledge at Month 6
Change from Baseline in Perceived Benefits to Colonoscopy at Month 6
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CRC mHealth interventionExperimental Treatment1 Intervention
Experimental group participants will have access to the CRC mHealth intervention.
Group II: Control EducationActive Control1 Intervention
Control condition participants will receive information about colorectal cancer and screening developed by the Centers for Disease Control.

Find a Location

Who is running the clinical trial?

ISA Associates, Inc.Lead Sponsor
5 Previous Clinical Trials
766 Total Patients Enrolled
Samantha L Leaf, Ph.D.Principal InvestigatorISA Associates
~42 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top